<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns:ifp="http://www.ifactory.com/press" xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9">
  <ifp:contentType>ARTICLE</ifp:contentType>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/14/1/article-pxvi.xml</sm:loc>
    <ifp:title>NCCN News</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/14/1/article-pxxxii.xml</sm:loc>
    <ifp:title>Oncology Research Program</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/14/1/article-pxliv.xml</sm:loc>
    <ifp:title>Re: “Putting an End to It!”</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/14/1/article-p1.xml</sm:loc>
    <ifp:title>Bringing Biosimilars to the Clinic: What's the Fuss?</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/14/1/article-p2.xml</sm:loc>
    <ifp:title>Are Advanced Radiation Therapy Technologies Required for Treating Patients With Hodgkin Lymphoma?</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/14/1/article-p8.xml</sm:loc>
    <ifp:title>A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/14/1/article-p19.xml</sm:loc>
    <ifp:title>Prostate Cancer, Version 1.2016</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/14/1/article-p38.xml</sm:loc>
    <ifp:title>Implementation of a Voice Messaging System is Associated With Improved Time-to-Treatment and Overall Survival in Patients With Hepatocellular Carcinoma</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/14/1/article-p47.xml</sm:loc>
    <ifp:title>Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/14/1/article-p57.xml</sm:loc>
    <ifp:title>Prevalence and Safety of Off-Label Use of Chemotherapeutic Agents in Older Patients With Breast Cancer: Estimates From SEER-Medicare Data</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/14/1/article-p70.xml</sm:loc>
    <ifp:title>Agreement in Metastatic Spinal Cord Compression</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/14/1/article-p82.xml</sm:loc>
    <ifp:title>Palliative Care Version 1.2016</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/14/1/article-p115.xml</sm:loc>
    <ifp:title>Enhancing Value for Patients With Cancer: Time to Treatment as a Surrogate for Integrated Cancer Care</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/14/suppl_1/article-pS-1.xml</sm:loc>
    <ifp:title>Optimizing Patient Care in Chronic Phase Chronic Myelogenous Leukemia: A Multidisciplinary Approach</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
</urlset>
